Tirofiban plus aspirin and clopidogrel for mild stroke
Part of Blood & lymphatic, Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a combination of a clot-preventing drug (tirofiban) followed by two antiplatelet drugs (aspirin and clopidogrel) can improve recovery in people who have had a mild stroke. It aims to find a better way to prevent further strokes or worsening symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You had a mild stroke that was not caused by a heart condition, and you can start treatment within 48 hours.
- Your stroke symptoms are mild (NIHSS score of 5 or less).
- You have not had a major bleed, recent surgery, or high bleeding risk (like blood thinners or low platelets).
- You do not have kidney failure, uncontrolled high blood pressure, or allergies to the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.
This trial tests whether combining a blood-thinning drug (tirofiban) with aspirin can improve recovery after a moderate stroke that started within the last 24 hours. It aims to see if this combination is safe and helps more than aspirin alone.
This trial tests whether adding aspirin to either ticagrelor or clopidogrel (two antiplatelet medicines) can help prevent another stroke in people who recently had a minor stroke or TIA affecting a large brain artery. It is for people who started antiplatelet treatment within 24 hours of their symptoms.
This trial tests a medication called tirofiban given intravenously after standard thrombolysis to see if it improves recovery in people with acute ischemic stroke. It is for those whose symptoms have not improved or are getting worse after initial treatment.
This trial tests the drug tirofiban (a blood thinner) to prevent another stroke in people who have had a mild stroke or high-risk TIA and have a narrowed artery in the brain. It must be started within 24 hours of symptoms.
This trial tests whether adding ticagrelor or cilostazol to aspirin is better than aspirin alone for preventing another stroke. It is for patients who recently had a minor stroke or a transient ischemic attack (TIA) caused by a blockage in a large artery.
Hear when a new Mild Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.